All terms in EFO
| Label | Id | Description |
|---|---|---|
| ST segment duration | EFO_0011033 | [Electrocardiography measurement of the duration from the end of the S wave to the start of the T wave] |
| fractional excretion of lactulose to mannitol ratio | EFO_0011032 | [The gold standard for functional measurements of intestinal permeability in humans is the lactulose/ mannitol test, which measures urinary excretion of the two orally administered non-metabolized sugars over a 6 h period. Analysis by high pressure liquid chromatography or liquid chromatography in combination with mass spectrometry is usually performed on urine samples.] |
| intestinal permeability measurement | EFO_0011031 | [Quantification of the intestinal permeability barrier status, for example measured by the ratio of the fractional excretion of lactulose to mannitol (LacMan ratio)] |
| C57BL/6NCrl | EFO_0011030 | [The C57BL/6NCrl is an inbred mouse strain derived from stock given to Charles River from the NIH in 1974.] |
| Pyropia yezoensis | NCBITaxon_2788 | |
| malate(2-) | CHEBI_15595 | [A C4-dicarboxylate resulting from deprotonation of both carboxy groups of malic acid.] |
| recessive spherocytosis | EFO_0011064 | [recessive spherocytosis is a congenital hemolytic anemia with a wide clinical spectrum (from symptom-free carriers to severe hemolysis) characterized by anemia, variable jaundice, splenomegaly and cholelithiasis inherited through a recessive inheritance pattern.] |
| recessive lissencephaly | EFO_0011063 | [Lissencephaly with an autosomal recessive inheritance pattern.] |
| GM15324 | CLO_0027182 | [DNA POLYMORPHISM DISCOVERY RESOURCE COLLECTION] |
| 2-methylcitrate (3-) | CHEBI_15598 | [A tricarboxylic acid trianion that is the conjugate base of 2-methylcitric acid.] |
| vascular toxicity | EFO_0011062 | [Toxicity that impairs the vascular system or damages its function. This can include hypertension, hypotension. ] |
| respiratory toxicity | EFO_0011060 | [Toxicity that impairs the respiratory system or damages its function. This can include bronchospasm, pulmonary toxicity, pulmonay hypertension, pulmonary embolism. ] |
| N(alpha)-acetyl-L-arginine | CHEBI_40521 | [An N-acetyl-L-amino acid that is L-arginine in which one of the hydrogens attached to the nitrogen is replaced by an acetyl group.] |
| extracellular vesicular exosome | GO_0070062 | [ A membrane-bounded vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. ] |
| psychiatric toxicity | EFO_0011059 | [Toxicity that causes psychiatric disorders. This can include anxiety, depression, schizophrenia, sleep disorder, suicide ideation, suicide attempt. It also can include disorders related to substance abuse such as drug dependence and substance-related disorders (see also 'Drug Misuse' term that includes the use of a drug to satisfy dependence).] |
| peripheral neurotoxicity | EFO_0011058 | [Toxicity that causes injury to the peripheral nervous system or damages its function. This can include Guillain Barre syndrome.] |
| nephrotoxicity | EFO_0011056 | [Toxicity that causes injury to the kidney or damages its function. This can include nephritis, renal failure, injury to kidney.] |
| musculoskeletal toxicity | EFO_0011055 | [Toxicity that causes injury to the muscles, bones, joints and connective tissues or damages its function. This can include scleroderma, Reynold's syndrome, Lupus erythematosus, allergic rhinitis, osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, rhabdomyolysis. ] |
| metabolic toxicity | EFO_0011054 | [Toxicity that causes impairs the (energy) metabolic system or damages its function. This can include lactic acidosis, obesity, hypochloremia, polydipsia, hyperkalemia, diabetes mellitus (type I and II) hyperglycemia, hypoglycemia, hyperlipidemia, gout, vitamin C deficiency. ] |
| (S)-malate(2−) | CHEBI_15589 | [An optically active form of malate having (S)-configuration.] |